Isogenica Limited, Cresset Group and Biolauncher Secure Funding from UK's Technology Strategy Board for a £1 Million Project to Develop New Small Molecule Drug Platform

Published: Jun 06, 2012

CAMBRIDGE, England--(BUSINESS WIRE)--Today Wednesday 6th June 2012, Isogenica and Biolauncher, Cambridge UK together with Cresset Group, Welwyn Garden City UK announce funding from the Technology Strategy Board, the UK’s innovation agency, for a £1M project to develop a highly-scalable approach to small molecule drug discovery.

Back to news